Treatment of histoplasmosis

Seminars in Respiratory Infections

Volumn 16, Issue 2, 2001, Pages 141-148

  Mocherla, Satish ^a   Wheat, L Joseph ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b Histoplasmosis Reference Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; KETOCONAZOLE; POSACONAZOLE;

ANTIFUNGAL ACTIVITY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

EID: 0034963581     PISSN: 08820546     EISSN: None     Source Type: Journal    
DOI: 10.1053/srin.2001.24244     Document Type: Review

References (69)

1. Outbreak of histoplasmosis associated with the 1970 Earth Day activities
2. An epidemic of histoplasmosis on the isthmus of Panama
3. Pericarditis as a manifestation of histoplasmosis during two large urban outbreaks
4. Erythema nodosum in an epidemic of histoplasmosis in Indianapolis
5. An epidemic of erythema multiforme and erythema nodosum caused by histoplasmosis
6. Surgical implications of sclerosing mediastinitis: A report of six cases and review of the literature
7. Acute histoplasmosis presenting as the adult respiratory distress syndrome
8. Acute pulmonary histoplasmosis presenting as adult respiratory distress syndrome: Effect of therapy on clinical and laboratory features
9. Cavitary histoplasmosis occurring during two large urban outbreaks: Analysis of clinical, epidemiologic, roentgenographic, and laboratory features
10. Disseminated histoplasmosis: Clinical and pathologic correlations
11. Chronic disseminated histoplasmosis: An investigation of its relationship to sarcoidosis
12. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice
13. A multicenter randomized trial comparing amphotericin B (AmB) and liposomal amphotericin B (AmBisome, LAmB) as induction therapy of disseminated histoplasmosis (DH) in AIDS patients
14. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome
15. Histoplasmosis: Recognition and treatment
16. Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immune deficiency syndrome
17. Fluconazole therapy for histoplasmosis
18. Diagnosis and management of fungal infections in AIDS
19. The course and prognosis of histoplasmosis
20. Experiences with histoplasmosis
21. Dysphagia due to mediastinal granulomas: Diagnosis with endoscopic ultrasonography
22. Fluconazole therapy in Histoplasma mediastinal granuloma
23. Tracheal obstruction secondary to Histoplasma mediastinal granuloma
24. Esophageal obstruction caused by mediastinal histoplasmosis: Beneficial results of operation
25. Mediastinal Histoplasma granuloma causing tracheal compression in a 4-year-old child
26. Surgical intervention in histoplasmosis
27. Mediastinal histoplasmosis granuloma: Evaluation with CT
28. Comparison of treated and untreated severe histoplasmosis
29. Treatment of chronic pulmonary histoplasmosis
30. Histoplasmosis cooperative study: Veterans Administration-Armed Forces Cooperative Study on histoplasmosis
31. Histoplasmosis cooperative study: Chronic pulmonary histoplasmosis treated with amphotericin B alone and with amphotericin B and triple sulfonamide
32. Follow-up of patients with chronic pulmonary histoplasmosis treated with amphotericin B
33. Itraconazole therapy for blastomycosis and histoplasmosis
34. Treatment of blastomycosis and histoplasmosis with ketoconazole: Results of a prospective randomized clinical trial
35. Treatment of disseminated and progressive cavitary histoplasmosis with ketoconazole
36. Mediastinal fibrosis complicating histoplasmosis
37. Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis
38. Sclerosing mediastinitis: Improved management with histoplasmosis titer and ketoconazole
39. Clinical manifestations of mediastinal fibrosis and histoplasmosis
40. Mediastinal granuloma and fibrosing mediastinitis
41. Progressive disseminated histoplasmosis as seen in adults
42. Disseminated histoplasmosis: Results of long-term follow-up
43. Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks
44. Histoplasmosis in the acquired immunodeficiency syndrome
45. Disseminated histoplasmosis in the acquired immune deficiency syndrome: Clinical findings, diagnosis and treatment, and review of the literature
46. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome
47. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome
48. Itraconazole maintenance treatment for histoplasmosis in AIDS: A prospective, multicenter trial
49. Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome
50. Repeatedly relapsing disseminated histoplasmosis: Clinical observations during long-term follow-up
51. Histoplasmosis relapse in patients with AIDS: Detection using Histoplasma capsulatum variety capsulatum antigen levels
52. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: Randomized, placebo-controlled, double-blind study
53. Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection?
54. Histoplasma capsulatum infections of the central nervous system: A clinical review
55. Active Histoplasma meningitis of 22 years' duration
56. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system
57. Amphotericin B concentration in cerebrospinal fluid or patients with AIDS and II cryptococcal meningitis
58. Lipsomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis
59. Amphotericin B combined with itraconazole or fluconazole for treatment of histoplasmosis
60. The probable role of benign histoplasmosis in the etiology of granulomatous uveitis
61. Histoplasmosis of the eye
62. Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis
63. Ocular histoplasmosis with retinitis in a patient with acquired immune deficiency syndrome
64. SCH57404, an antifungal agent possessing the rare sodaricin skeleton and a tricyclic sugar moiety
65. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi
66. Efficacy of nikkomycin Z in the treatment of murine histoplasmosis
67. Comparison of nikkomycin Z with amphotericin B and itraconazole for treatment of histoplasmosis in a murine model
68. Treatment of histoplasmosis with MK-991 (L-743,872)
69. Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model